Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Quizartinib
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quizartinib 17.7mg tablets
0801050CTAAAAAA
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Quizartinib 26.5mg tablets
0801050CTAAABAB
|
Quizartinib | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Vanflyta 17.7mg tablets
0801050CTBBAAAA
|
Vanflyta | Quizartinib | Malignant Disease and Immunosuppression | No data available |
|
Vanflyta 26.5mg tablets
0801050CTBBABAB
|
Vanflyta | Quizartinib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.